site stats

Ironwood pharmaceuticals news

WebApr 14, 2024 · In other Ironwood Pharmaceuticals news, COO Jason Rickard sold 16,746 shares of the stock in a transaction on Monday, February 27th. The shares were sold at an average price of $11.41, for a total ... WebApr 15, 2024 · The stock, however, is off -83.80% from where it was a year ago. Additionally, there is a loss of -2.06% for Cumberland Pharmaceuticals Inc. (CPIX) in last trading while the stock has seen an overall depriciation of -26.73%% over the past year. The PE ratio stands at 11.39 for Ironwood Pharmaceuticals Inc., compared to 70.08 for AstraZeneca PLC.

Everence Capital Management Inc. Has $558,000 Stock Holdings …

WebApr 13, 2024 · ONTONAGON, Mich. — Troy Armour, of Ontonagon, passed away unexpectedly March 16, 2024. He was born Nov. 3, 1987, to Cathy and Dennis Armour. … WebJan 29, 2024 · Astellas Pharma Inc. (TSE:4503) and Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) announced today top-line results indicating that the Phase III clinical trial of linaclotide conducted in Japan in adults with chronic constipation (CC) met its primary endpoint. Linaclotide is approved in Japan as the first prescription treatment for adults … ray\\u0027s pool and spa facebook https://anthologystrings.com

Will Ironwood Pharmaceuticals, Inc. (IRWD) Stay at the Bottom of …

WebIronwood Pharmaceuticals 27,221 followers 1d Edited Our Director of Research Quality Assurance, Cheryl McCarthy, CQA, CBA, RQAP-GCP will be giving the President’s speech as well as chairing the... WebApr 14, 2024 · Ironwood Pharmaceuticals Stock Performance IRWD opened at $11.10 on Friday. The stock has a market capitalization of $1.71 billion, a PE ratio of 11.44 and a beta of 0.95. Ironwood Pharmaceuticals, Inc. has a one year low … WebIronwood Pharmaceuticals’ commitment to redefining the standard of care for patients suffering from GI diseases and disorders is unwavering. We understand that debilitating GI diseases exist, and countless patients need meaningful and effective medicines. ray\\u0027s portsmouth ri

Ironwood Pharmaceuticals, Inc. - Press Releases

Category:Ironwood Pharmaceuticals, Inc. - Press Releases

Tags:Ironwood pharmaceuticals news

Ironwood pharmaceuticals news

Ironwood Pharmaceuticals, Inc. (IRWD) - Stock Analysis

WebApr 10, 2024 · Ironwood Pharmaceuticals, Inc is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics... WebIt is hard to get excited after looking at Ironwood Pharmaceuticals' (NASDAQ:IRWD) recent performance, when its stock... Zacks Strength Seen in Xencor (XNCR): Can Its 5.3% Jump …

Ironwood pharmaceuticals news

Did you know?

WebMar 2, 2024 · Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Could Be 40% Below Their Intrinsic Value Estimate Simply Wall St March 2, 2024, 7:09 AM · 6 min read Key Insights The projected fair value... WebApr 11, 2024 · Ironwood Pharmaceuticals - IRWD News Today $10.52 +0.10 (+0.96%) (As of 03/31/2024 06:55 PM ET) Compare Today's Range $10.43 $10.62 50-Day Range $10.37 …

WebApr 6, 2024 · Ironwood Pharmaceuticals, Inc. is a gastrointestinal (GI) healthcare company, which is advancing the treatment of GI diseases and redefining the standard of care for GI patients. It is develops and commercializes GI product opportunities in areas of significant unmet need, leveraging its demonstrated expertise and capabilities in GI diseases. WebMar 9, 2024 · Ironwood Pharmaceuticals News More News Seeking Alpha 22d Ironwood Pharmaceuticals Non-GAAP EPS of $0.27 beats by $0.01, revenue of $107.2M misses by $1.02M, guidance in-line

WebApr 13, 2024 · 2024-23 Season Snow: 220.1 inches 2024-22 Season Snow: 182.3 2024-21 Season Snow: 84.4 2024-20 Season Snow: 169.3 2024-19 Season Snow: 182.8 WebApr 12, 2024 · Shares of IRWD opened at $10.77 on Wednesday. Ironwood Pharmaceuticals, Inc. has a 1 year low of $9.73 and a 1 year high of $12.66. The company has a market cap of $1.66 billion, a price-to ...

WebIronwood Pharmaceuticals to Participate in Upcoming Investor Conferences BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that management will participate in the following investor conferences: Cowen 43rd Annual Health Care Conference on Monday, March 6, 2024 at …

Web2 days ago · Ironwood Pharmaceuticals IRWD rose 3.4% amid speculation about an activist investor in the gastro intestinal drug company.; Gordon Haskett in a note on Thursday … ray\u0027s polish fireWebApr 14, 2024 · Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23... ray\\u0027s polish fireWeb1 hour ago · The counties faced "severe conditions and sustained serious damage caused by widespread flooding," according to a news release sent by the governor's office Friday. … ray\u0027s pool supplies richmond vaWebJan 4, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and … simply right fiber capsulesWebFeb 13, 2024 · BOSTON--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental New Drug Application (sNDA) for LINZESS ® (linaclotide) for the treatment of children and adolescents ages 6 … ray\\u0027s place kent ohioWebApr 11, 2024 · Ironwood Pharmaceuticals ( NASDAQ: IRWD) said on Tuesday that COO Jason Rickard's last day in the company will be May 12. The company is set to eliminate the role of COO, and Rickard's ... simply right exceed dog foodWebApr 14, 2024 · Ironwood Pharmaceuticals has a one year low of $9.73 and a one year high of $12.66. Ironwood Pharmaceuticals ( NASDAQ:IRWD – Get Rating) last announced its … ray\\u0027s popcorn